On Tuesday, the Department of Health and Human Services (HHS) Office of Inspector General (OIG) published Advisory Opinion No. 19-02, advising that OIG would not pursue enforcement under the Anti-Kickback Statute (AKS) or the beneficiary inducement provision of the Civil Monetary Penalties Law (beneficiary inducement CMP) regarding a pharmaceutical manufacturer's proposal to loan a limited-function smartphone to financially needy patients to facilitate collection of drug-adherence data.